期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
临床基因组测序解读与报告专家共识
1
作者 卢宇蓝 李国壮 +31 位作者 王雅琼 徐可欣 董欣然 蔡继昊 吴冰冰 王慧君 方萍 王剑 王华 孙路明 叶勇裕 李晴 刘雅萍 刘丽 刘宁 刘嘉琦 宋昉 杨琳 邱正庆 陈泽夫 罗华夏 郭丹 郝婵娟 赵森 黄尚志 彭镜 蔡小强 睢瑞芳 李林康 吴南 周文浩 张抒扬 《遗传》 北大核心 2025年第3期314-328,共15页
基因组测序(genome sequencing,GS)是一种全面且系统地检测个体核基因组和线粒体基因组DNA序列的技术,旨在识别遗传变异并研究这些变异在人类健康和疾病发生发展中的作用。作为一种应用越来越广泛的检测技术,GS凭借高通量、高准确性和... 基因组测序(genome sequencing,GS)是一种全面且系统地检测个体核基因组和线粒体基因组DNA序列的技术,旨在识别遗传变异并研究这些变异在人类健康和疾病发生发展中的作用。作为一种应用越来越广泛的检测技术,GS凭借高通量、高准确性和全面性的优势,为临床诊断提供了重要支持。然而,其复杂的数据分析与解读对专业知识和经验提出了较高要求,也带来了诸多挑战。运用GS技术进行遗传病分子诊断会涉及临床应用的伦理与技术问题,包括知情同意、诊断性数据解读、报告范围和内容等。本专家共识总结了临床基因组测序(clinical GS,c GS)的核心流程,明确了检测范围与技术局限性,提供了数据质控、分析、注释及变异解读的关键步骤,并对报告内容和知情同意的争议性问题展开讨论。本共识旨在帮助相关从业人员正确理解和规范使用临床基因组测序技术,提升遗传病诊断的准确性,优化技术的临床效用,推动医学科学研究的进步。 展开更多
关键词 遗传罕见病 基因组测序 高通量测序数据分析 变异解读 遗传检测报告
暂未订购
Semi-quantitatively Predicting the Residence Time of Three Natural Products on Endothelin Receptor A by Peak Profiling Using the Receptor Functionalized Macroporous Silica Gel as Stationary Phase 被引量:2
2
作者 Ping li Bowen Shi +8 位作者 linkang li Jiatai Yin Qingqing Yao Tian Yang Xiaomin Huang Xu Ji Chaoni Xiao Qian li Xinfeng Zhao 《Journal of Analysis and Testing》 EI CSCD 2023年第1期40-52,共13页
Drug-receptor interaction analysis has been broadly adopted as a tool for the evaluation of the drug-like property.Nowadays,growing evidence has demonstrated that drug e fficacy and safety are highly related to reside... Drug-receptor interaction analysis has been broadly adopted as a tool for the evaluation of the drug-like property.Nowadays,growing evidence has demonstrated that drug e fficacy and safety are highly related to residence time,which equals the reciprocal of the dissociation rate constant(k_(d))of a drug to its target protein.Using endothelin receptor A(ET_(A)R)as a probe,we immobilized the receptor on the surface of macroporous silica gel through a covalent interaction between the epidermal growth factor tyrosine kinase(EGFR)at the C terminal of ET_(A)R and the covalent inhibitor ibrutinib modified on the gel in a one-step fashion.The a ffinity stationary phase was used to semi-quantitatively determine the residence time of natural products on ET_(A)R and evaluate their drug-like property.The k_(d)values of three specific ligands(bosentan,macitentan,and ambrisentan)to ET_(A)R were determined by nonlinear chromatography,peak profiling and peak_(d)ecay.Compared the data determined in free solution of the three methods,peak profiling is considered as the best-fit method for k_(d)determination.Thus,peak profiling was applied for predicting the residence time of three natural products(ferulic acid,berberine,and palmatine)on ET_(A)R.With the longest residence time of 61.11±3.47 s on ET_(A)R,palmatine was evaluated as the most potent compound,which could be developed as a long-acting lead for the receptor.We demonstrate that the high-performance a ffinity chromatography with immobilized ET_(A)R is an alternative for the semi-quantitative measurement of residence time for the drug-like property evaluation of natural products. 展开更多
关键词 Endothelin receptor A Residence time Natural product Drug-like property
原文传递
National-scale genomic diagnosis of rare diseases in China
3
作者 Xiaodong Luan Ye Jin +18 位作者 liping Guan Peng liu Hailong Feng Dingding Zhang Jingdan Chen Weida liu Fangyuan li Anqi Wang Kun Zhao Ruirui He Hankui liu Shida Zhu Shuang Yang lijian Zhao Jian Wang linkang li Dan Guo Jianguo Zhang Shuyang Zhang 《Science Bulletin》 2025年第20期3324-3328,共5页
In China,an estimated 48.42-82.11 million individuals are affected by rare diseases.This estimate is derived from the Orphanet database,based on the global population of 7.55 billion and China's population of 1.39... In China,an estimated 48.42-82.11 million individuals are affected by rare diseases.This estimate is derived from the Orphanet database,based on the global population of 7.55 billion and China's population of 1.39 billion in 2017(source:National Bureau of Statistics of China)[1,2]. 展开更多
关键词 national scale genomic diagnosis population estimate orphanet database orphanet databasebased rare diseases China
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部